Health News Archive - June 05, 2012
2012 report from Amgen Canada and Let's Talk Science - Spotlight on Science Learning: A benchmark of Canadian talent MISSISSAUGA, ON, June 5, 2012 /CNW/ - A report
QUINCY, Mass., June 5, 2012 /PRNewswire/ -- Connected Living®, a mission-based organization helping senior citizens live richer,
LEESBURG, Va., June 5, 2012 /PRNewswire/ -- RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide,
DANBURY, Conn., June 5, 2012 /PRNewswire/ -- Biodel Inc.
SAN DIEGO, June 5, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System
CAMPBELL, Calif., JUNE 5, 2012 /PRNewswire/ -- Rick Noodleman, M.D., announces that Age Defy Dermatology and Wellness(TM), Inc.
ABOUT ISIS PHARMACEUTICALS, INC.Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012. Isis' patents provide strong and extensive protection for its drugs and technology. Additional information about Isis is available at www.isispharm.com
BOWIE, Md., June 5, 2012 /PRNewswire/ -- MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced the formal launch of its new name - Inovalon, Inc.
DENVER, June 5, 2012 /PRNewswire/ -- Medical Marijuana, Inc.
INCLINE VILLAGE, Nev., June 5, 2012 /PRNewswire/ -- PDL BioPharma, Inc.